- Display 45 Products per page
Direct-to-Consumer Pharmaceutical Marketing 2005: Controversies Continue
Published: April 1, 2005 | Price: $1,995.00 – $3,990.00
This timely overview of direct to consumer (DTC) pharmaceutical marketing examines the numerous issues surrounding DTC practices and markets, using industry and consumer publications as well as interviews with industry experts. The topics examined include: DTC marketing spending by product, DTC marketing spending by company DTC marketing spending by media channel The ROI debate on the cost-effectiveness of DTC marketing expenditures Arguments for and against DTC marketing by its proponents and critics DTC marketing regulations in the U.S. and selected...
Computer-Assisted Surgical Systems: A Market Briefing
Published: February 1, 2005 | Price: $995.00 – $1,990.00
Computer-based technologies offer significant potential for improving the clinical outcomes of patients. Computer software and hardware, as well as the systems they control, have begun to impact the manner in which surgeons design, plan, simulate and perform surgery. In the last few years, automated and computer-assisted techniques have found increased use in surgical procedures as tools for performing difficult neurosurgery, cranio-facial surgery and some orthopedic procedures. These techniques give the surgeon more advanced capabilities than were available previously, such as...
Neurological Catheters: A Market Briefing
Published: February 1, 2005 | Price: $995.00 – $1,990.00
Neurological catheters, also known as microcatheters, are small devices that can navigate the intricate intracranial vasculature of the brain. These catheters--some on the market, others in development--are used for a variety of applications, including aneurysm occlusion, chronic pain relief, targeted drug delivery, tumor embolization, treating vascular malformations, brachytherapy, and vasospasm therapy. They also promise to be extremely useful in the delivery of therapeutic genes or stem cells to patients who may have a variety of neurological diseases. This report analyzes...
The Worldwide Market for Cancer Therapeutics
Published: February 1, 2005 | Price: $3,500.00 – $7,000.00
The world market for cancer therapeutics is growing at a brisk double-digit pace, with revenues surpassing $40 billion this year. This study looks at each therapeutic approach in turn, reporting and forecasting revenues from 2002 through 2009. Market share by leading competitor in each therapy type is estimated for the year 2004. Therapy types considered, include: Chemotherapy Hormone Therapy Radiation Therapy Immunotherapy and Biotherapy, and Adjunctive Therapies The study focuses on current and emerging markets, products in development, and trends...
Autism Therapeutics: A Market Briefing
Published: January 15, 2005 | Price: $995.00 – $1,990.00
Despite the traditional notion that nothing therapeutic can be accomplished for the 1.5 million Americans with autism and the 2 million more throughout the world, there are pharmacologic approaches to the disease that are providing some help for patients and garnering revenues for drug companies. This Market Briefing reviews the market for drugs used in the treatment of autism and related disorers, including Antidepressants, Anti-Anxiety drugs, Anti-psychotics, Anti-convulsants, and CNS stimulants for ADHD-related symptoms, forecasting revenues through 2009 gloabally and...
Cell-Based Diagnostics: Technology, Applications, and Markets
Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples, the complete blood count, and the enumeration of disease-bearing cells have been...
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put on the back burner due to technical difficulties. The six...
The U.S. Market for Over-The-Counter Pain Medication
Published: January 1, 2005 | Price: $3,000.00 – $6,000.00
The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace. The report provides a comprehensive analysis of the pain medication products that are currently in the...
U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The
Published: November 15, 2004 | Price: $4,995.00 – $9,990.00
This unprecedented study provides detailed market data on products and segments in the retail OTC diagnostic market in the United States. In addition to market size, growth and competitive share information on each of six testing categories plus testing accessories, the report contains the results of a major consumer survey conducted jointly by Kalorama Information and The Telephone Centre, Inc., focusing on consumer attitudes and awareness of OTC testing products and their marketing channels. This valuable consumer information, never before...
The World Market For Pain Management Drugs And Devices: Applications And Top Products
Published: November 1, 2004 | Price: $3,500.00 – $7,000.00
The market for pain management products is growing at a brisk pace, with some segments moving ahead at over 20%. The future for specialized pharmaceutical and medical device products in this market is bright and new opportunities exist for emerging treatment modalities as well. The report presents the most up-to-date information about the top-producing pain management products in terms of revenues, and analyzes the market by specific pain sites as well. The report concentrates on the following application areas: Burn...
The World Market for Vaccines
Published: November 1, 2004 | Price: $3,500.00 – $7,000.00
This report covers pediatric and adult preventive vaccine products and provides an analysis of therapeutic vaccines for cancer treatment. In assessing the market for vaccine products, Kalorama Information provides sales data for the 2001-2003 historical years, the 2004 base year, and the 2001 through 2010 forecast years. Revenues are expressed in terms of manufacturersā annual sales and in current U.S. dollars. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources...
Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures, 2002-2006
Published: October 1, 2004 | Price: $395.00 – $790.00
Based on findings from Kalorama Informationās research study Facial Cosmetic Surgery and Rejuvenation Markets: Business, Technologies, and Competitive Intelligence (July 2004), this summary covers the top five surgeries and an āotherā category. The top five procedures are: Breast augmentation/reduction Liposuction Rytidectomy (face lifts) Blepharoplasty (eyelid lift) Rhinoplasty (nose job) The analysis includes data on procedures and revenues for surgery but not market data for conventional surgical instruments and equipment. The āotherā category includes such procedures as tummy tucks , buttocks...
Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential
Published: October 1, 2004 | Price: $995.00 – $1,990.00
Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Downās syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...
Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential
Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Informationās U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential
Published: October 1, 2004 | Price: $995.00 – $1,990.00
The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic constitution. Differences in drug metabolism may lead to varying adverse events or more pronounced adverse events in different individuals, and differing metabolism may also lead...
New Anticoagulant Therapies: A Market Briefing
Published: October 1, 2004 | Price: $895.00 – $1,790.00
There is a pressing need for new anticoagulant therapeutics in human medicine. To meet this need, developers are reformulating traditional cornerstone therapeutics such as heparin and looking to new classes such as DTIs to prevent stroke and myocardial infarction and treat deep vein thrombosis and a host of other emerging indications. This briefing analyzes the potential world medical markets for new anticoagulant therapies. Revenue projections through 2010 are made for four geographic regions and for two potentially blockbuster products. This...
Wellness Market Opportunities in the Aging American Population: Alternative Medicine Markets for Age-Related Health Issues
Published: September 1, 2004 | Price: $3,500.00 – $7,000.00
With an aging population in the United States, the incidence of prevalence of age-related diseases and disorders is expected to mount rapidly over the next decade. Since senior citizens already consume a disproportionate amount of healthcare dollars, the economic picture will only go from bad to worse insofar as healthcare is concerned. The solution to this problem, for this generation and the future, is prevention. The new emphasis on prevention opens up a scope of opportunity in the alternative care...
Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential
Published: September 1, 2004 | Price: $3,500.00 – $7,000.00
Neural and muscular stimulation by electronic and magnetic means have evolved into a burgeoning product development and commercial fields. For decades, transcutaneous electronic nerve stimulation (TENS) has been a mainstay in the pain relief arsenal. Through the years, as biocompatibility problems were being solved, electrode and sensor implants developed into a multitude of technologies with healthcare applications. The growing approval of these applications by government regulators and the growing acceptance by insurance carriers have driven the market. These techniques have...
Molecular Nanotechnology in Medicine: A Market Briefing
Published: September 1, 2004 | Price: $895.00 – $1,790.00
Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer therapeutics, specialized drug delivery, diagnostics, and topical therapies, reviewing what companies are doing in those markets.
U.S. Market for Over-the-Counter Gastrointestinal Products, 2nd Edition, The
Published: August 1, 2004 | Price: $1,995.00 – $5,990.00
The market for OTC Gastrointestinal products has gone through several significant changes in the past 5 years, most of which have to do with the Rx-to-OTC switches of two types of gastroesophageal reflux disease (GERD) drugs: H2 receptor antagonists and proton pump inhibitors (PPIs). This report on the U.S. market for OTC GI products presents a description of upper gastrointestinal conditions and diseases, the OTC treatments available, and clinical and business trends affecting the market, consumer behavior and attitudes, and...
Immunomodulators in Cancer Therapy: Emerging Products and Markets
Published: August 1, 2004 | Price: $3,500.00 – $7,000.00
This Kalorama Information report focuses on current and emerging immunomodulators for cancer. The report covers both current and emerging cancer immunomodulators in detail. The report includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development are profiled. These include bladder, breast, colorectal, head/neck, kidney, lung, ovarian, pancreatic, and prostate cancers, as well as leukemia, lymphoma, melanoma, multiple myeloma, and neuroblastoma. The current market...
Molecular Diagnostics for Blood Banking Applications: Testing volume, cost per test, and market potential
Published: August 1, 2004 | Price: $995.00 – $1,910.00
Blood banking has been the most dynamic testing segment to adopt molecular diagnostics approaches since their introduction. Screening for HIV, HCV and HBV in donated blood, plasma and organs has largely been done by immunoassay procedures. In conjunction with background screening, this has become a very effective approach toward guaranteeing the safety of the blood/organ supply. However, there is a lag time between infection with these viruses and the production of antibodies against them. In some cases, such as HBV,...
Ambulatory Infusion Pumps in Pain Management: A Market Briefing
Published: August 1, 2004 | Price: $895.00 – $1,790.00
After years of neglect, concerns over pain, how it is assessed and managed on a patient-by-patient basis have captured the attention of health care professionals and the public. There are a variety of issues that have acted to draw this attention, including the high prevalence of pain, continuing evidence that pain is undertreated and a growing awareness of the negative consequences of poor pain management. Infusion pumps were first introduced in the 1960s. These devices ushered in a whole new...
Inhaled Insulin: A Market Briefing
Published: July 1, 2004 | Price: $895.00 – $1,790.00
Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear. This...
Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing
Published: July 1, 2004 | Price: $3,500.00 – $7,000.00
After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies are searching for business solutions to streamline operations and cut costs as they strive to continue generating above-average shareholder returns. Outsourcing has become an integral, ongoing element of pharmaceutical companiesā business...
Facial Cosmetic Surgery and Rejuvenation Markets
Published: July 1, 2004 | Price: $3,500.00 – $7,000.00
New technologies and alternatives to traditional cosmetic surgery have opened up a huge new market for anti-aging products. Cosmetic facial rejuvenation is no longer the purview of plastic surgeons, but represents a booming cash business for a large number of dermatologist and other practitioners. Botox, dermal fillers, resurfacing modalities, lasers, and other alternatives are creating a dynamic and growing marketplace and finding millions of eager patients. This 400-page report examines the competing technologies, procedures, and options available to physicians, non-physician...
Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets
Published: June 1, 2004 | Price: $3,500.00 – $7,000.00
In 2003, the market for monoclonal antibodies in the treatment of cancer is just short of $2.8 billion and growing at a phenomenal rate. The market is fueled by leading products such as Rituxan and Herceptin; however, other products continue to demand more attention each year. This study reviews market data for the years 2001 to the present and forecasts the market to 2008, including Kaloramaās estimates of the competitive market share in 2008 based on the current pipeline and...
Market for Generic Biologics: Issues, Trends, and Market Potential, The
Published: June 1, 2004 | Price: $1,500.00 – $3,000.00
Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be no generic form of biologics. That is, the complex process of creating biologics, means that traditional definitions of bioequivalence used in the generic drug industry do not (or may not)...
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited
Published: June 1, 2004 | Price: $2,995.00 – $5,990.00
Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and high-speed automation. Today, reality has begun to creep in: HTS and UHTS have not lived up to their hype. R&D productivity is not improving, in fact it may be declining. In the...
U.S. Market for Molecular Diagnostics, 2nd Edition
Published: May 1, 2004 | Price: $3,500.00 – $7,000.00
Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based on molecular testing approaches. The primary molecular diagnostics approaches are based on two major database sciences (genomics and proteomics) and their relationship to disease and...
The U.S. Market for Interventional Radiology Products
Published: April 1, 2004 | Price: $3,500.00 – $7,000.00
Changing demographics are spurring dynamic growth in the interventional radiology market. The angioplasty balloon, coronary stent, vascular closure, and other associated equipment markets will experience healthy growth over the next 5 years. Persons over the age of 65 will be a major segment of the population in coming years. Chronic diseases and unhealthy habits such as smoking, lack of exercise, and poor diet are resulting in an epidemic of obesity and concomitant cardiac conditions. These factors and others will drive...
Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease
Published: April 1, 2004 | Price: $1,995.00 – $3,990.00
The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...
Diagnostics for Emerging Infectious Disease Threats, Volumes I – III
Published: March 1, 2004 | Price: $3,995.00 – $7,990.00
A host of new and old infectious diseases have emerged on the world stage, presenting familiar and novel challenges to public health officials. New strains of once controlled bacteria, new immunocomprimised patient populations, and new bioterror threats have spurred diagnostics companies to develop new tests and kits to meet the demand. Kalorama has assembled the vital data developers and marketers need to understand the competitive and commercial landscape in three volumes: Prion Disease; Viral Disease ; and Baterial & Protozoal...
Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003
Published: March 1, 2004 | Price: $795.00 – $1,590.00
The hard-fought battle over Medicare's prescription drug benefit is over, but the long-term effects of the new law are still unclear. Exactly who will benefit and by how much? Is it a victory for big pharma? Initial reactions are not always correct, and this examination into the true implications for pharmaceutical markets looks at all the facts. This market briefing from Kalorama describes and assesses the provisions of the "Medicare Prescription Drug, Improvement and Modernization Act of 2003" and predicts...
Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
Published: March 1, 2004 | Price: $3,500.00 – $7,000.00
Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting targets for compounds intended to inhibit or slow the mechanisms involved in their function or growth. This report highlights the research into, and the current and potential key world markets for, products that...
Trends in Cell Therapeutics: Promise and Reality
Published: March 1, 2004 | Price: $3,500.00 – $7,000.00
Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem cell and tissue therapeutics, and products based on combinations of cell therapy, gene manipulation, and tissue engineering. The report provides world market projections 2002-2007, discusses market trends and issues including...
Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices
Published: March 1, 2004 | Price: $2,995.00 – $5,990.00
Cardiovascular disease includes chronic conditions such as hypertension, congestive heart failure and atherosclerosis, as well as such acute conditions as myocardial infarction and cardiac arrest. While cardiovascular disease may be diagnosed at any age, it is most prevalent in later years, particularly among sedentary individuals who are also overweight or obese. With the aging of the "Baby Boom" generation, a generation that has defined the term "couch potato" and has grown up on and maintained a diet of fast-food, the...
The Worldwide Market For Dialysis Equipment, Supplies, and Services
Published: March 1, 2004 | Price: $3,500.00 – $7,000.00
The dialysis industry enjoys a unique space in healthcare sector. The industry has its feet spread across the two most lucrative segments of the sector viz. medical devices industry (dialysis products and supplies segment) and healthcare services industry (dialysis services segment). Needless to say, the dialysis industry remains a robust, nearly $50 billion global industry that has managed to fuel its growth engine with a modest, but respectable 6% to 7% rise growth rate in the past 5 years. The...
U.S. Market for OTC Diet Aids, The
Published: February 1, 2004 | Price: $3,000.00 – $6,000.00
Diet Aids are among the most rapidly growing categories of over-the-counter (OTC) products. Between 1998 and 2003, growth was driven by two main factors: changes in laws and lawsuits relating to the industry, and changes in consumer attitudes toward weight loss. Because both of these factors are subject to rapid and unpredictable shifts, the diet aids category remains a highly volatile market. The consumer attitude towards OTC diet aids has shown extreme changes during the last couple of years. While...
Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The
Published: February 1, 2004 | Price: $3,500.00 – $7,000.00
This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fourth time Kalorama Information has comprehensively studied the dermatology markets. For this latest edition, Kalorama completely re-evaluated the market from the ground up, and in addition to the usual primary interviewing of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of...
Emerging Cancer Vaccine Market, The
Published: February 1, 2004 | Price: $3,500.00 – $7,000.00
Immunologic approaches to cancer therapy are not only increasing in reputation and number, but the market for these products is increasingly becoming a reality. Vaccines are in the forefront of this approach to cancer, and the handful of cancer vaccine products currently on the market for bladder, colon, and skin cancer are soon to be joined by many more with indications for more wide-spread forms, including lung, breast, ovarian, prostate, leukemia, and others. This new study from Kalorama discusses the...
Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III
Published: January 1, 2004 | Price: $3,500.00 – $7,000.00
The cost of drug development has soared during the past ten years compelling pharmaceutical and biotechnology companies to look for new, smarter ways of conducting clinical research. Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. This industry has evolved from providing limited clinical trial services...
Type II Diabetes: The 45 Market in the United States for Drugs and Diagnostics
Published: January 1, 2004 | Price: $2,995.00 – $5,990.00
Type II diabetes is a metabolic disease the increases in incidence and prevalence with age. Type II diabetes (also known as "adult onset diabetes" and "non-insulin dependent diabetes") is a disease of glucose metabolism in which the individual becomes resistant to the glucose produced by the pancreas. As a result, glucose is not properly metabolized and serum glucose levels are increased, resulting in numerous complications vascular, renal, neurological and ophthalmological complications as the patient ages. This volume of the Markets...
Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease
Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...
Drug Delivery Technology and Applications: A summary of Kalorama’s market research, 2001-2003
Published: November 7, 2003 | Price: $746.00 – $1,492.00
Over the past three years, Kalorama Information's analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery Volume III: Pulmonary Drug Delivery Volume IV: Transdermal and Transmucousal Drug Delivery Volume V: Advanced Drug Delivery This series segmented the market by technology and included an innovative analysis that estimated...